Search

everythinglearnresearchcommunity

for

Search:↓

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Using a blow dryer in a certain way can cause localized hair damage with bubble formation inside the hair.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The model and estimator can predict drug exposure in kidney transplant patients well.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Skin symptoms are important for diagnosing infections in children.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

NK cells play a role in skin diseases like eczema and psoriasis.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Blood tests confirmed a baby in the womb had a CMV infection.